- - --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN ISSUER
PURSUANT TO RULE 13A-16 OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934
FILING NO. 2 FOR THE MONTH OF JANUARY, 2000
Visible Genetics Inc.
---------------------
(Exact name of Registrant)
700 Bay Street, Suite 1000, Toronto ON, Canada M5g 1Z6
------------------------------------------------------
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports
under cover Form 20-F or Form 40-F
Form 20-F X Form 40-F
--- ---
Indicate by check mark whether the registrant by furnishing the information
contained in this Form is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes No X
--- ---
- - --------------------------------------------------------------------------------
VISIBLE GENETICS INC.
On January 19, 2000, Visible Genetics Inc. (the "Company") issued press
release to announce that it has received notice of a patent suit. The press
release is filed as an exhibit to this Form 6-K.
The Company hereby incorporates by reference this Form 6-K into the
Company's outstanding Registration Statements on Form F-3 (File Nos. 333-67607,
333-68939, 333-91155 and 333-94649) and all of the Company's outstanding
Registration Statements on Form S-8 (including, but not limited to,
File Nos. 333-6454 and 333-8804).
Exhibit 1. Press Release issued January 19, 2000.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
VISIBLE GENETICS INC.
Date: January 19, 2000 By: /s/ Richard T. Daly
-------------------
Name: Richard T. Daly
Title: President and CEO